Chang CY - Search Results

1

Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanoma.

Chakraborty B, Byemerwa J, Shepherd J, Haines CN, Baldi R, Gong W, Liu W, Mukherjee D, Artham S, Lim F, Bae Y, Brueckner O, Tavares K, Wardell SE, Hanks BA, Perou CM, Chang CY, McDonnell DP. Chakraborty B, et al. Among authors: chang cy. J Clin Invest. 2021 Dec 1;131(23):e151347. doi: 10.1172/JCI151347. J Clin Invest. 2021. PMID: 34637400 Free PMC article.

2

Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta.

Paige LA, Christensen DJ, Grøn H, Norris JD, Gottlin EB, Padilla KM, Chang CY, Ballas LM, Hamilton PT, McDonnell DP, Fowlkes DM. Paige LA, et al. Among authors: chang cy. Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3999-4004. doi: 10.1073/pnas.96.7.3999. Proc Natl Acad Sci U S A. 1999. PMID: 10097152 Free PMC article.

3

Peptide antagonists of the human estrogen receptor.

Norris JD, Paige LA, Christensen DJ, Chang CY, Huacani MR, Fan D, Hamilton PT, Fowlkes DM, McDonnell DP. Norris JD, et al. Among authors: chang cy. Science. 1999 Jul 30;285(5428):744-6. doi: 10.1126/science.285.5428.744. Science. 1999. PMID: 10426998

4

Development of peptide antagonists that target estrogen receptor beta-coactivator interactions.

Hall JM, Chang CY, McDonnell DP. Hall JM, et al. Among authors: chang cy. Mol Endocrinol. 2000 Dec;14(12):2010-23. doi: 10.1210/mend.14.12.0561. Mol Endocrinol. 2000. PMID: 11117531

5

Temporally distinct and ligand-specific recruitment of nuclear receptor-interacting peptides and cofactors to subnuclear domains containing the estrogen receptor.

Schaufele F, Chang CY, Liu W, Baxter JD, Nordeen SK, Wan Y, Day RN, McDonnell DP. Schaufele F, et al. Among authors: chang cy. Mol Endocrinol. 2000 Dec;14(12):2024-39. doi: 10.1210/mend.14.12.0572. Mol Endocrinol. 2000. PMID: 11117532

6

Development of peptide antagonists that target estrogen receptor-cofactor interactions.

McDonnell DP, Chang CY, Norris JD. McDonnell DP, et al. Among authors: chang cy. J Steroid Biochem Mol Biol. 2000 Nov 30;74(5):327-35. doi: 10.1016/s0960-0760(00)00109-6. J Steroid Biochem Mol Biol. 2000. PMID: 11162941 Review.

7

Estrogen receptor-cofactor interactions as targets for novel drug discovery.

Norris JD, Chang C, McDonnell DP. Norris JD, et al. Ernst Schering Res Found Workshop. 2001;(34):181-201. doi: 10.1007/978-3-662-04645-6_10. Ernst Schering Res Found Workshop. 2001. PMID: 11394045 Review. No abstract available.

8

Glucocorticoids manifest androgenic activity in a cell line derived from a metastatic prostate cancer.

Chang CY, Walther PJ, McDonnell DP. Chang CY, et al. Cancer Res. 2001 Dec 15;61(24):8712-7. Cancer Res. 2001. PMID: 11751389

9

Capitalizing on the complexities of estrogen receptor pharmacology in the quest for the perfect SERM.

McDonnell DP, Chang CY, Norris JD. McDonnell DP, et al. Among authors: chang cy. Ann N Y Acad Sci. 2001 Dec;949:16-35. doi: 10.1111/j.1749-6632.2001.tb03999.x. Ann N Y Acad Sci. 2001. PMID: 11795348

10

Evaluation of ligand-dependent changes in AR structure using peptide probes.

Chang CY, McDonnell DP. Chang CY, et al. Mol Endocrinol. 2002 Apr;16(4):647-60. doi: 10.1210/mend.16.4.0818. Mol Endocrinol. 2002. PMID: 11923463

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,833 results

Search Page